内镜下射频消融联合塑料支架与单纯支架置入治疗不可切除肝外胆道癌的多中心随机对照试验
这项多中心随机对照试验纳入174例不可手术的局部晚期或转移性胆管癌或壶腹癌患者,比较内镜下射频消融(RFA)联合塑料支架置入与单纯塑料支架置入的疗效与安全性。主要终点总生存期在RFA组显著更高(中位14.3 vs 9.2个月;RFA组急性胆囊炎更常见。
要点
- RFA联合塑料支架可显著延长不可切除肝外胆道癌患者的总生存期。
- 胆管癌亚组同样显示生存获益,黄疸控制和支架通畅时间无显著改善。
- RFA组急性胆囊炎发生率更高,其他不良事件两组相当。
核心结论
- 与单纯塑料支架置入相比,附加RFA可能改善未接受全身治疗的不可手术原发性肝外胆道癌患者的总生存期和生活质量。
研究设计与样本
- 多中心随机对照试验,从3家三级中心招募局部晚期或转移性胆管癌或壶腹癌且不适合手术的患者。
- 合格患者按1:1随机分配至RFA联合塑料支架置入组或单纯塑料支架置入组,两组均接受2次预定干预,间隔约3个月。
- 共174例参与者完成了2次索引内镜干预,主要终点为总生存期。
主要发现
- 两组在黄疸控制或支架通畅持续时间方面无显著差异。
临床怎么用
- 对于不可手术且未接受全身治疗的肝外胆道癌患者,可考虑在塑料支架置入基础上附加RFA以延长生存并改善生活质量。
- RFA治疗时需警惕急性胆囊炎风险,术后应加强相关监测与处理。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We sought to compare the efficacy and safety between endoscopic radiofrequency ablation (RFA) and stent placement alone in patients with unresectable extrahepatic biliary cancer (EBC). METHODS: In this randomized controlled trial, patients with locally advanced or metastatic cholangiocarcinoma (CCA) or ampullary cancer who were unsuitable for surgery were recruited from 3 tertiary centers. Eligible patients were randomly assigned to RFA plus plastic stent placement (RFA group) or plastic stent placement alone (stent placement alone group) in a 1:1 ratio. Both groups underwent 2 scheduled interventions with an interval of approximately 3 months. The primary outcome was overall survival (OS). RESULTS: Altogether, 174 participants completed the 2 index endoscopic interventions. No significant differences in baseline characteristics were noted between the 2 groups. The median OS was significantly higher in the RFA group (14.3 vs 9.2 months; hazard ratio, .488; 95% confidence interval, .351-.678; P < .001). A survival benefit was also shown in patients with CCA (13.3 vs 9.2 months; hazard ratio, .546; 95% confidence interval, .386-.771; P < .001). However, no significant between-group differences were found in jaundice control or stent patency duration. The postprocedural Karnofsky performance scores were significantly higher in the RFA group until 9 months (all P < .001). Adverse events were comparable between the 2 groups (27.6% vs 19.5%, P = .211), except for acute cholecystitis, which was more frequently observed in the RFA group (9 vs 0, P = .003). CONCLUSIONS: Compared with stent placement alone, additional RFA may improve OS and quality of life of patients with inoperable primary EBC who do not undergo systemic treatments. (Clinical trial registration number: NCT01844245.).
引用
- Gao DJ, Yang JF, Ma SR, et al. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. Gastrointest Endosc. 2020. PMID: 33359435. doi:10.1016/j.gie.2020.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。